P.055 Epidemiologic features of pituitary adenoma patients requiring surgical treatment: large North American patient population based study

Abstract

Background: The surgical treatment of pituitary adenoma has evolved greatly over the decades. In order to better understand the patient population and their surgical treatment, we conducted an institutional review for pituitary adenoma surgery using the endoscopic endonasal trans-sphenoidal (EETS) approach. Methods: A retrospective review of all EETS cases for pituitary tumor resection was performed between November 2009 and June 2016. Patient characteristics, tumor type, endocrine data, operation characteristics were extracted from medical records. Preoperative MRI images were reviewed. The SIPAP classification was applied to the pituitary tumors. Postoperative patient data were extracted for the available follow-up period. Results: 232 cases were identified. Functional tumors were present in 29% of the cohort. Complete excision was most common for functioning tumors (49%) compared to nonfunctioning tumors (26%). There were no major vascular injuries. Hormone replacement with cortisol was required transiently in 70% of patients, with thyroid hormone replacement occurring in 40% of the cohort. Conclusions: From this large North American cohort nearly 30% of operated pituitary tumors were functioning. More commonly, these tumors were completely resected compared to the nonfunctioning group. The most commonly replaced hormone following EETS surgery was cortisol and this was largely transient.